Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination
@article{Moscarello2002PaclitaxelA, title={Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination}, author={M. Moscarello and B. Mak and T. A. Nguyễn and D. Wood and F. Mastronardi and S. Ludwin}, journal={Multiple Sclerosis}, year={2002}, volume={8}, pages={130 - 138} }
Treatment with paclitaxel by four intraperitoneal injections (20 mg/kg) 1 week apart attenuated clinical signs in a spontaneously demyelinating model, if given with onset of clinical signs. If given at 2 months of age (1 month prior to clinical signs), disease was almost completely prevented. The astrogliosis, prominent in our model, was reversed by paclitaxel as determined by astrocyte counts and quantitation of GFAP. Electron microscopic examination of affected regions at 2.5 months… CONTINUE READING
Figures, Tables, and Topics from this paper
42 Citations
Synergy between paclitaxel plus an exogenous methyl donor in the suppression of murine demyelinating diseases
- Medicine
- Multiple sclerosis
- 2007
- 22
Attenuation of Experimental Autoimmune Encephalomyelitis and Nonimmune Demyelination by IFN-β plus Vitamin B12: Treatment to Modify Notch-1/Sonic Hedgehog Balance 1
- Medicine, Biology
- The Journal of Immunology
- 2004
- 71
- PDF
Differential expression of sonic hedgehog immunoreactivity during lesion evolution in autoimmune encephalomyelitis.
- Medicine, Biology
- Journal of neuropathology and experimental neurology
- 2005
- 37
- Highly Influenced
- PDF
Micellar paclitaxel improves severe psoriasis in a prospective phase II pilot study.
- Medicine
- Journal of the American Academy of Dermatology
- 2004
- 53
The Microtubule-Modulating Drug Epothilone D Alters Dendritic Spine Morphology in a Mouse Model of Mild Traumatic Brain Injury
- Medicine
- Front. Cell. Neurosci.
- 2018
- 5
- PDF
Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system
- Biology, Medicine
- Disease Models & Mechanisms
- 2008
- 107
- PDF
Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology
- Biology, Medicine
- Neurochemical Research
- 2016
- 41
Natalizumab: A new treatment for relapsing remitting multiple sclerosis
- Medicine
- Therapeutics and clinical risk management
- 2007
- 79
- PDF
References
SHOWING 1-10 OF 57 REFERENCES
Demyelination in a transgenic mouse: A model for multiple sclerosis
- Biology, Medicine
- Journal of neuroscience research
- 1993
- 95
Inhibition of experimental allergic encephalomyelitis in the Lewis rat by paclitaxel
- Medicine
- Journal of Neuroimmunology
- 2000
- 37
Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions
- Medicine
- 1993
- 477
Over‐Expression of the DM‐20 Myelin Proteolipid Causes Central Nervous System Demyelination in Transgenic Mice
- Biology, Medicine
- Journal of neurochemistry
- 1995
- 64
Myelin basic protein in experimental allergic encephalomyelitis is not affected at the posttranslational level: Implications for demyelinating disease
- Medicine
- Journal of neuroscience research
- 1996
- 13
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
- Biology, Medicine
- Annals of neurology
- 2000
- 2,887
- PDF
Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis.
- Biology, Medicine
- Brain : a journal of neurology
- 2000
- 195
- PDF
Acute multiple sclerosis (marburg type) is associated with developmentally immature myelin basic protein
- Medicine
- Annals of neurology
- 1996
- 248
Experimental allergic encephalomyelitis induced by the peptide encoded by exon 2 of the MBP gene, a peptide implicated in remyelination
- Biology, Medicine
- Journal of Neuroimmunology
- 1994
- 33